REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc. (Nasdaq: RVPH) is a clinical-stage biopharmaceutical company focused on central nervous system and respiratory disorders that completed its SPAC merger with Tenzing Acquisition Corp. in December 2020. Tenzing, sponsored by Tenzing LLC, completed its IPO in 2019 targeting the healthcare and life sciences sector. The 10-Q filed January 14, 2021 represents one of the company's first periodic disclosures as a publicly traded entity following the de-SPAC transaction, reflecting its transition to a listed operating company. RVPH's pipeline centers on novel neuropsychiatric and CNS drug candidates at the clinical stage. Sign up at SpacDesk for full filing history, deal timelines, and sponsor data on RVPH and hundreds of other SPAC transactions.